Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-13

FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DERMOTIC (Fluocinonide acetonide)

Snippet

SUPPL AP for DERMOTIC (FLUOCINOLONE ACETONIDE)